GIN Oy delivers a Point of Care diagnostics manufacturing solution for a ground breaking skin cancer detection product

Skin cancer is one of the most common cancers in the world, accounting for nearly half of all cancers. It has been estimated that nearly half of all Americans who live to age 65 will develop skin cancer at least once. Skin cancer is the most common form of cancer in the United States.

Each year there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate, lung and colon. Over the past three decades, more people have had skin cancer than all other cancers combined. The incidence of both non-melanoma and melanoma skin cancers has been increasing over the past decades. Currently, between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin…read more

Global Innovation Network Ltd awarded grant to develop a manufacturing solution for rapid, molecular diagnostic test for malaria

New test being developed to enable faster, more tailored treatment for malaria. Over 200 million cases of malaria annually.

Global Innovation Network Ltd (“GIN”), a private Finland-based developer and manufacturer of rapid diagnostic test production and medical device manufacturing solutions, today announces the award of a 500 000 € grant from the European Commission’s Framework Programme 7 to help fund a three year project (DIAGMAL) to develop a new rapid molecular diagnostic test for malaria. This test will be used directly on fresh blood samples to confirm the presence of Plasmodium parasites, the infectious agent that causes malaria. There are currently no rapid molecular tests for the Plasmodium parasite on the market.

Malaria is a life-threatening disease with around 3.3 billion people, half of the world's population, at risk(1). In 2010, there were thought to be…read more

GIN™ Kolibri CNC at EMO exhibition in Hannover

Global Innovation Network Ltd. (GIN) and Mitsubishi Electric Europe have developed new GIN™ Kolibri CNC machine in cooperation. GIN has integrated Mitsubishi’s servo motors and CNC controller in GIN™Kolibri CNC machine to make it powerful, precise und user-friendly.

The new GIN™Kolibri CNC will be displayed for the first time in 16.9-21.9.2013 (Hall 25, Stand C08) in cooperation with Mitsubishi at EMO exhibition in Hannover, Germany.